{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:20:17Z","timestamp":1790734817845,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and is primarily characterised by a respiratory disease. However, SARS-CoV-2 can directly infect vascular endothelium and subsequently cause vascular inflammation, atherosclerotic plaque instability and thereby result in both endothelial dysfunction and myocardial inflammation\/infarction. Interestingly, up to 50% of patients suffer from persistent exercise dyspnoea and a post-viral fatigue syndrome (PVFS) after having overcome an acute COVID-19 infection. In the present study, we assessed the presence of coronary microvascular disease (CMD) by cardiovascular magnetic resonance (CMR) in post-COVID-19 patients still suffering from exercise dyspnoea and PVFS. N\u2009=\u200922 patients who recently recovered from COVID-19, N\u2009=\u200916 patients with classic hypertrophic cardiomyopathy (HCM) and N\u2009=\u200917 healthy control patients without relevant cardiac disease underwent dedicated vasodilator-stress CMR studies on a 1.5-T MR scanner. The CMR protocol comprised cine and late-gadolinium-enhancement (LGE) imaging as well as velocity-encoded (VENC) phase-contrast imaging of the coronary sinus flow (CSF) at rest and during pharmacological stress (maximal vasodilation induced by 400\u00a0\u00b5g IV regadenoson). Using CSF measurements at rest and during stress, global myocardial perfusion reserve (MPR) was calculated. There was no difference in left ventricular ejection-fraction (LV-EF) between COVID-19 patients and controls (60% [57\u201363%] vs. 63% [60\u201366%], p\u2009=\u2009NS). There were only N\u2009=\u20094 COVID-19 patients (18%) showing a non-ischemic pattern of LGE. VENC-based flow measurements showed that CSF at rest was higher in COVID-19 patients compared to controls (1.78\u00a0ml\/min [1.19\u20132.23\u00a0ml\/min] vs. 1.14\u00a0ml\/min [0.91\u20131.32\u00a0ml\/min], p\u2009=\u20090.048). In contrast, CSF during stress was lower in COVID-19 patients compared to controls (3.33\u00a0ml\/min [2.76\u20134.20\u00a0ml\/min] vs. 5.32\u00a0ml\/min [3.66\u20135.52\u00a0ml\/min], p\u2009=\u20090.05). A significantly reduced MPR was calculated in COVID-19 patients compared to healthy controls (2.73 [2.10\u20134.15\u201311] vs. 4.82 [3.70\u20136.68], p\u2009=\u20090.005). No significant differences regarding MPR were detected between COVID-19 patients and HCM patients. In post-COVID-19 patients with persistent exertional dyspnoea and PVFS, a significantly reduced MPR suggestive of CMD\u2014similar to HCM patients\u2014was observed in the present study. A reduction in MPR can be caused by preceding SARS-CoV-2-associated direct as well as secondary triggered mechanisms leading to diffuse CMD, and may explain ongoing symptoms of exercise dyspnoea and PVFS in some patients after COVID-19 infection.<\/jats:p>","DOI":"10.1038\/s41598-021-95277-z","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T10:03:01Z","timestamp":1627898581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Stefanos","family":"Drakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Chatzantonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bietenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik Bernard","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Fonfara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"issue":"23","key":"95277_CR1","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli, B. et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75(23), 2950\u20132973 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10234","key":"95277_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234), 1417\u20131418 (2020).","journal-title":"Lancet"},{"issue":"2","key":"95277_CR3","first-page":"95","volume":"22","author":"F Ciceri","year":"2020","unstructured":"Ciceri, F. et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): An atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 22(2), 95\u201397 (2020).","journal-title":"Crit Care Resusc."},{"key":"95277_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.thromres.2020.05.039","volume":"192","author":"F Al-Ani","year":"2020","unstructured":"Al-Ani, F., Chehade, S. & Lazo-Langner, A. Thrombosis risk associated with COVID-19 infection A scoping review. Thromb. Res. 192, 152\u2013160 (2020).","journal-title":"Thromb. Res."},{"issue":"11","key":"95277_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsend","year":"2020","unstructured":"Townsend, L. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS\u00a0One 15(11), e0240784 (2020).","journal-title":"PLoS\u00a0One"},{"issue":"12","key":"95277_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/biomedicines8120626","volume":"8","author":"GP Bulfamante","year":"2020","unstructured":"Bulfamante, G. P. et al. Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement. Biomedicines 8(12), 626 (2020).","journal-title":"Biomedicines"},{"issue":"3","key":"95277_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jmri.1051","volume":"13","author":"JW Koskenvuo","year":"2001","unstructured":"Koskenvuo, J. W. et al. Global myocardial blood flow and global flow reserve measurements by MRI and PET are comparable. J. Magn. Reson. Imaging 13(3), 361\u2013366 (2001).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"11","key":"95277_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s00392-018-1279-2","volume":"107","author":"M Bietenbeck","year":"2018","unstructured":"Bietenbeck, M., Florian, A., Shomanova, Z., Meier, C. & Yilmaz, A. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging. Clin. Res. Cardiol. 107(11), 1062\u20131070 (2018).","journal-title":"Clin. Res. Cardiol."},{"issue":"2","key":"95277_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002649","volume":"5","author":"S Kato","year":"2016","unstructured":"Kato, S. et al. Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J. Am. Heart Assoc. 5(2), e002649 (2016).","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"95277_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jacc.2017.06.028","volume":"70","author":"S Kato","year":"2017","unstructured":"Kato, S. et al. Stress perfusion coronary flow reserve versus cardiac magnetic resonance for known or suspected CAD. J. Am. Coll. Cardiol. 70(7), 869\u2013879 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"95277_CR11","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1161\/01.CIR.101.23.2696","volume":"101","author":"J Schwitter","year":"2000","unstructured":"Schwitter, J. et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: A comparison with positron emission tomography. Circulation 101(23), 2696\u20132702 (2000).","journal-title":"Circulation"},{"issue":"8","key":"95277_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ehjci\/jew315","volume":"18","author":"Z Shomanova","year":"2017","unstructured":"Shomanova, Z. et al. Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging. Eur. Heart J. Cardiovasc. Imaging 18(8), 851\u2013859 (2017).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"23","key":"95277_CR13","first-page":"12609","volume":"24","author":"L Saba","year":"2020","unstructured":"Saba, L. et al. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review. Eur. Rev. Med. Pharmacol. Sci. 24(23), 12609\u201312622 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"95277_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","volume":"143","author":"D Pellegrini","year":"2021","unstructured":"Pellegrini, D. et al. Microthrombi as a major cause of cardiac injury in COVID-19: A pathologic study. Circulation 143, 1031\u20131042 (2021).","journal-title":"Circulation"},{"issue":"13","key":"95277_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/heartjnl-2011-301352","volume":"98","author":"A Yilmaz","year":"2012","unstructured":"Yilmaz, A. & Sechtem, U. Angina pectoris in patients with normal coronary angiograms: Current pathophysiological concepts and therapeutic options. Heart 98(13), 1020\u20131029 (2012).","journal-title":"Heart"},{"issue":"17","key":"95277_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2014","unstructured":"Crea, F., Camici, P. G. & Bairey Merz, C. N. Coronary microvascular dysfunction: An update. Eur. Heart J. 35(17), 1101\u20131111 (2014).","journal-title":"Eur. Heart J."},{"key":"95277_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10456-020-09753-7","volume":"24","author":"A Rovas","year":"2021","unstructured":"Rovas, A. et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis 24, 145\u2013157 (2021).","journal-title":"Angiogenesis"},{"issue":"10","key":"95277_CR18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik, T. J. et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 116(10), 1666\u20131687 (2020).","journal-title":"Cardiovasc. Res."},{"issue":"18","key":"95277_CR19","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/01.CIR.0000146891.31481.CF","volume":"110","author":"KB Vallbracht","year":"2004","unstructured":"Vallbracht, K. B., Schwimmbeck, P. L., Kuhl, U., Seeberg, B. & Schultheiss, H. P. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110(18), 2938\u20132945 (2004).","journal-title":"Circulation"},{"issue":"11","key":"95277_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/hrt.2007.131383","volume":"94","author":"A Yilmaz","year":"2008","unstructured":"Yilmaz, A. et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 94(11), 1456\u20131463 (2008).","journal-title":"Heart"},{"issue":"1","key":"95277_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12968-020-00667-3","volume":"22","author":"S Kato","year":"2020","unstructured":"Kato, S. et al. Incremental prognostic value of coronary flow reserve determined by phase-contrast cine cardiovascular magnetic resonance of the coronary sinus in patients with diabetes mellitus. J. Cardiovasc. Magn. Reson. 22(1), 73 (2020).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"95277_CR22","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1394","author":"AK Mishra","year":"2020","unstructured":"Mishra, A. K., Lal, A., Sahu, K. K., Kranis, M. & Sargent, J. Quantifying and reporting cardiac findings in imaging of COVID-19 patients. Monaldi Arch. Chest Dis. https:\/\/doi.org\/10.4081\/monaldi.2020.1394 (2020).","journal-title":"Monaldi Arch. Chest Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95277-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95277-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:06:03Z","timestamp":1670069163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95277-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95277-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15667"}}